STING1 and neoplasm: Both in vitro and in vivo results demonstrated that MAPN can precisely activate the cGAS‐STING pathway and block the PD‐1/PD‐L1 pathway, and thus initiating robust and durable anti‐tumor immune responses to inhibit the growth, recurrence, and metastasis of malignant tumors.